In the afternoon of January 17, 2014, the leaders of Shanghai Pharmacovigilance Bureau accompanied by the director of the Safety Supervision Division of Xi'an, Suzhou and Jiangxi Pharmacovigilance Bureau visited Shanghai Centron Medical Technology Co.

       The delegation of FDA visited the company's exhibition hall, R&D department and production department. During the inspection, the party director listened carefully to the report about the company's development history, scientific research strength, development planning, main products, product lines and so on. For the high-tech projects the company is engaged in, the leader recognized it very much. The company was encouraged to further increase innovation, enhance the company's scientific research capability, accelerate the industrialization of science and technology, and provide more advanced domestic self-developed products for hospitals.